Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04428333 |
| Title | Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma |
| Acronym | INDUCE-4 |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | SWE | ROU | POL | ITA | IRL | GBR | FRA | ESP | DNK | DEU | CAN | BRA | BEL | AUS | ARG |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Duarte | California | 91010 | United States | Details | |
| GSK Investigational Site | Buenos Aires | 1012 | Argentina | Details | ||
| GSK Investigational Site | Ciudad AutOnoma de Buenos Aires | C1426ABP | Argentina | Details | ||
| GSK Investigational Site | Oro Verde Entre RIos | E3100XAD | Argentina | Details | ||
| GSK Investigational Site | Rosario | S2000DBS | Argentina | Details | ||
| GSK Investigational Site | San Miguel de TucumAn | T4000 | Argentina | Details | ||
| GSK Investigational Site | Blacktown | 2148 | Australia | Details | ||
| GSK Investigational Site | Heidelberg | 3084 | Australia | Details | ||
| GSK Investigational Site | Melbourne | 3000 | Australia | Details | ||
| GSK Investigational Site | Woolangabba | 4102 | Australia | Details | ||
| GSK Investigational Site | Bruxelles | 1070 | Belgium | Details | ||
| GSK Investigational Site | Edegem | 2650 | Belgium | Details | ||
| GSK Investigational Site | Curitiba | 81520-060 | Brazil | Details | ||
| GSK Investigational Site | SAo Paulo | 01246-000 | Brazil | Details | ||
| GSK Investigational Site | VitOria | 29043-260 | Brazil | Details | ||
| GSK Investigational Site | Edmonton | Alberta | T6G 1Z2 | Canada | Details | |
| GSK Investigational Site | Hamilton | Ontario | L8V 5C2 | Canada | Details | |
| GSK Investigational Site | London | Ontario | N6A 4G5 | Canada | Details | |
| GSK Investigational Site | Toronto | Ontario | M4N 3M5 | Canada | Details | |
| GSK Investigational Site | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| GSK Investigational Site | Montreal | Quebec | H2X 3E4 | Canada | Details | |
| GSK Investigational Site | Koebenhavn | 2100 | Denmark | Details | ||
| GSK Investigational Site | Bordeaux | 33000 | France | Details | ||
| GSK Investigational Site | Lyon cedex 08 | 69373 | France | Details | ||
| GSK Investigational Site | Paris | 75005 | France | Details | ||
| GSK Investigational Site | Poitiers | 86021 | France | Details | ||
| GSK Investigational Site | Strasbourg | 67200 | France | Details | ||
| GSK Investigational Site | Berlin | 12203 | Germany | Details | ||
| GSK Investigational Site | Hannover | 30625 | Germany | Details | ||
| GSK Investigational Site | Leipzig | 04103 | Germany | Details | ||
| GSK Investigational Site | Ulm | 89075 | Germany | Details | ||
| GSK Investigational Site | Dublin | 8 | Ireland | Details | ||
| GSK Investigational Site | Brescia | 25123 | Italy | Details | ||
| GSK Investigational Site | Firenze | 59100 | Italy | Details | ||
| GSK Investigational Site | Milano | 20132 | Italy | Details | ||
| GSK Investigational Site | Napoli | 80131 | Italy | Details | ||
| GSK Investigational Site | Roma | 00144 | Italy | Details | ||
| GSK Investigational Site | Savona | 17100 | Italy | Details | ||
| GSK Investigational Site | Osaka | 541-8567 | Japan | Details | ||
| GSK Investigational Site | Osaka | 589-8511 | Japan | Details | ||
| GSK Investigational Site | Tokyo | 104-0045 | Japan | Details | ||
| GSK Investigational Site | Tokyo | 135-8550 | Japan | Details | ||
| GSK Investigational Site | Daegu | 42601 | Korea, Republic of | Details | ||
| GSK Investigational Site | Gyeonggi-do | 10408 | Korea, Republic of | Details | ||
| GSK Investigational Site | Hwasun | 58128 | Korea, Republic of | Details | ||
| GSK Investigational Site | Incheon | 21565 | Korea, Republic of | Details | ||
| GSK Investigational Site | Seoul | 05505 | Korea, Republic of | Details | ||
| GSK Investigational Site | Seoul | 137-701 | Korea, Republic of | Details | ||
| GSK Investigational Site | Bydgoszcz | 85-796 | Poland | Details | ||
| GSK Investigational Site | Gdynia | 81-519 | Poland | Details | ||
| GSK Investigational Site | Gliwice | 44-102 | Poland | Details | ||
| GSK Investigational Site | Lublin | 20-090 | Poland | Details | ||
| GSK Investigational Site | Tomaszow Mazowiecki | 97-200 | Poland | Details | ||
| GSK Investigational Site | Warszawa | 02-781 | Poland | Details | ||
| GSK Investigational Site | Bucuresti | 021389 | Romania | Details | ||
| GSK Investigational Site | Cluj Napoca | 400015 | Romania | Details | ||
| GSK Investigational Site | Craiova | 200347 | Romania | Details | ||
| GSK Investigational Site | Floresti | 407280 | Romania | Details | ||
| GSK Investigational Site | Otopeni | 075100 | Romania | Details | ||
| GSK Investigational Site | Suceava | 720284 | Romania | Details | ||
| GSK Investigational Site | Pushkin | 196603 | Russian Federation | Details | ||
| GSK Investigational Site | Barcelona | 08035 | Spain | Details | ||
| GSK Investigational Site | Madrid | 28040 | Spain | Details | ||
| GSK Investigational Site | Madrid | 28041 | Spain | Details | ||
| GSK Investigational Site | Madrid | 28046 | Spain | Details | ||
| GSK Investigational Site | Madrid | 28050 | Spain | Details | ||
| GSK Investigational Site | Valencia | 46026 | Spain | Details | ||
| GSK Investigational Site | Stockholm | SE-171 64 | Sweden | Details | ||
| GSK Investigational Site | London | SW3 6JJ | United Kingdom | Details | ||
| GSK Investigational Site | Nottingham | NG5 1PB | United Kingdom | Details | ||
| GSK Investigational Site | Sutton | SM2 5PT | United Kingdom | Details |